[1] İNCE Ö B, ?EVIK M, ÖZGÜR E G, et al. Risk factors and genetic characterization of bovine respiratory syncytial virus in the inner Aegean Region, Turkey[J]. Trop Anim Health Prod, 2021, 54(1):4. [2] SUDARYATMA P E, MEKATA H, KUBO M, et al. Co-infection of epithelial cells established from the upper and lower bovine respiratory tract with bovine respiratory syncytial virus and bacteria[J]. Vet Microbiol, 2019, 235:80-85. [3] SANTOS-RIVERA M, WOOLUMS A R, THORESEN M, et al. Bovine respiratory syncytial virus (BRSV) infection detected in exhaled breath condensate of dairy calves by near-infrared aquaphotomics[J]. Molecules, 2022, 27(2):549. [4] MAHMOUD A H A, SLATE J R, HONG S, et al. Supplementing a Saccharomyces cerevisiae fermentation product modulates innate immune function and ameliorates bovine respiratory syncytial virus infection in neonatal calves[J]. J Anim Sci, 2020, 98(8):skaa252. [5] JIA S, YAO X, YANG Y Q, et al. Isolation, identification, and phylogenetic analysis of subgroup Ⅲ strain of bovine respiratory syncytial virus contributed to outbreak of acute respiratory disease among cattle in Northeast China[J]. Virulence, 2021, 12(1):404-414. [6] ZHANG J, WANG W, YANG M J, et al. Development of a one-step multiplex real-time PCR assay for the detection of viral pathogens associated with the bovine respiratory disease complex[J]. Front Vet Sci, 2022, 9:825257. [7] CHANG Y M, YUE H, TANG C. Prevalence and molecular characteristics of bovine respiratory syncytial virus in beef cattle in China[J]. Animals, 2022, 12(24):3511. [8] DÍAZ F E, GUERRA-MAUPOME M, MCDONALD P O, et al. A recombinant BCG vaccine is safe and immunogenic in neonatal calves and reduces the clinical disease caused by the respiratory syncytial virus[J]. Front Immunol, 2021, 12:664212. [9] MAINA T W, GREGO E A, BRODERICK S, et al. Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection[J]. Front Immunol, 2023, 14:1186184. [10] DE JONG R, STOCKHOFE-ZURWIEDEN N, BONSING J, et al. ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves[J]. Nat Commun, 2022, 13(1):6142. [11] SACCO R E, MENA I, PALMER M V, et al. An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection[J]. Sci Rep, 2022, 12(1):22552. [12] FURZE J, WERTZ G, LERCH R, et al. Antigenic heterogeneity of the attachment protein of bovine respiratory syncytial virus[J]. J Gen Virol, 1994, 75(Pt 2):363-370. [13] JOBE F, SIMPSON J, HAWES P, et al. Respiratory syncytial virus sequesters NF-κB subunit p65 to cytoplasmic inclusion bodies to inhibit innate immune signaling[J]. J Virol, 2020, 94(22):e01380-20. [14] SCHMIDT U, BEYER J, POLSTER U, et al. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein g protects against challenge with wild-type BRSV[J]. J Virol, 2002, 76(23):12355-12359. [15] PASTEY M K, SAMAL S K. Analysis of bovine respiratory syncytial virus envelope glycoproteins in cell fusion[J]. J Gen Virol, 1997, 78(Pt 8):1885-1889. [16] KARGER A, SCHMIDT U, BUCHHOLZ U J. Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes:G and F proteins bind heparin[J]. J Gen Virol, 2001, 82(Pt 3):631-640. [17] CUI G L, LIU H C, LI X G, et al. Preliminary functional and phylogeographic analyses of the 72 nucleotide duplication region in the emerging human respiratory syncytial virus ON1 strain attachment glycoprotein gene[J]. Biomed Pharmacother, 2020, 123:109800. [18] TAPIA L I, SHAW C A, AIDEYAN L O, et al. Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas[J]. PLoS One, 2014, 9(3):e90786. [19] BUCHHOLZ U J, GRANZOW H, SCHULDT K, et al. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV):effects on host range and evaluation as a live-attenuated HRSV vaccine[J]. J Virol, 2000, 74(3):1187-1199. [20] STOPE M B, KARGER A, SCHMIDT U, et al. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins[J]. J Virol, 2001, 75(19):9367-9377. [21] CHANG Y M, TANG C, YUE H. Molecular epidemiological investigation of bovine respiratory syncytial virus in yaks[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(5):2030-2041. (in Chinese) 常益铭, 汤承, 岳华. 牦牛源牛呼吸道合胞体病毒的分子流行病学调查[J]. 畜牧兽医学报, 2023, 54(5):2030-2041. [22] GARCÍA-BEATO R, MELERO J A. The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner[J]. J Gen Virol, 2000, 81(Pt 4):919-927. [23] ESCRIBANO-ROMERO E, RAWLING J, GARCÍA-BARRENO B, et al. The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans[J]. J Virol, 2004, 78(7):3524-3532. [24] RUSSELL C J, HURWITZ J L. Sendai virus-vectored vaccines that express envelope glycoproteins of respiratory viruses[J]. Viruses, 2021, 13(6):1023. [25] STINE L C, HOPPE D K, KELLING C L. Sequence conservation in the attachement glycoprotein and antigenic diversity among bovine respiratory syncytial virus isolates[J]. Vet Microbiol, 54(3/4):201-221. [26] DORELEIJERS J F, LANGEDIJK J P M, HÅRD K, et al. Solution structure of the immunodominant region of protein g of bovine respiratory syncytial virus[J]. Biochemistry, 1996, 35(47):14684-14688. [27] LEME R A, DALL AGNOL A M, BALBO L C, et al. Molecular characterization of Brazilian wild-type strains of bovine respiratory syncytial virus reveals genetic diversity and a putative new subgroup of the virus[J]. Vet Quart, 2020, 40(1):83-96. [28] FURZE J M, ROBERTS S R, WERTZ G W, et al. Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity[J]. Virology, 1997, 231(1):48-58. [29] LANGEDIJK J P M, DE GROOT B L, BERENDSEN H J C, et al. Structural homology of the central conserved region of the attachment protein g of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor[J]. Virology, 1998, 243(2):293-302. [30] GORMAN J J, MCKIMM-BRESCHKIN J L, NORTON R S, et al. Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein[J]. J Biol Chem, 2001, 276(42):38988-38994. [31] HOTARD A L, LAIKHTER E, BROOKS K, et al. Functional analysis of the 60-nucleotide duplication in the respiratory syncytial virus Buenos Aires strain attachment glycoprotein[J]. J Virol, 2015, 89(16):8258-8266. [32] DE WAAL L, YÜKSEL S, BRANDENBURG A H, et al. Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein[J]. J Virol, 2004, 78(4):1775-1781. [33] VARGA S M, WISSINGER E L, BRACIALE T J. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses[J]. J Immunol, 2000, 165(11):6487-6495. [34] LANGEDIJK J P, MELOEN R H, TAYLOR G, et al. Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus[J]. J Virol, 1997, 71(5):4055-4061. [35] YOLITZ J, SCHWING C, CHANG J L, et al. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120[J]. Proc Natl Acad Sci U S A, 2018, 115(10):2443-2448. [36] OOMENS A G P, WERTZ G W. trans-complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission[J]. J Virol, 2004, 78(17):9064-9072. [37] SCHLENDER J, ZIMMER G, HERRLER G, et al. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection[J]. J Virol, 2003, 77(8):4609-4616. [38] LAWLOR H A, SCHICKLI J H, TANG R S. A single amino acid in the F2 subunit of respiratory syncytial virus fusion protein alters growth and fusogenicity[J]. J Gen Virol, 2013, 94(Pt 12):2627-2635. [39] LÓPEZ J A, PEÑAS C, GARCÍA-BARRENO B, et al. Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus[J]. J Virol, 1990, 64(2):927-930. [40] CALDER L J, GONZÁLEZ-REYES L, GARCÍA-BARRENO B, et al. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies[J]. Virology, 2000, 271(1):122-131. [41] COLLINS P L, HUANG Y T, WERTZ G W. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus[J]. Proc Natl Acad Sci U S A, 1984, 81(24):7683-7687. [42] SUN Z W, PAN Y B, JIANG S B, et al. Respiratory syncytial virus entry inhibitors targeting the F protein[J]. Viruses, 2013, 5(1):211-225. [43] MAGRO M, ANDREU D, GÓMEZ-PUERTAS P, et al. Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein[J]. J Virol, 2010, 84(16):7970-7982. [44] BLAIS N, GAGNÉ M, HAMURO Y, et al. Characterization of Pre-F-GCN4t, a modified human respiratory syncytial virus fusion protein stabilized in a noncleaved prefusion conformation[J]. J Virol, 2017, 91(13):e02437-16. [45] OOMENS A G P, MEGAW A G, WERTZ G W. Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein[J]. J Virol, 2003, 77(6):3785-3798. [46] OOMENS A G P, BEVIS K P, WERTZ G W. The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production[J]. J Virol, 2006, 80(21):10465-10477. [47] MESHRAM C D, BAVISKAR P S, OGNIBENE C M, et al. The respiratory syncytial virus phosphoprotein, matrix protein, and fusion protein carboxy-terminal domain drive efficient filamentous virus-like particle formation[J]. J Virol, 2016, 90(23):10612-10628. [48] ZIMMER G, TROTZ I, HERRLER G. N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus[J]. J Virol, 2001, 75(10):4744-4751. [49] LOPES B R P, DA SILVA G S, DE LIMA MENEZES G, et al. Serine proteases in neutrophil extracellular traps exhibit anti-respiratory syncytial virus activity[J]. Int Immunopharmacol, 2022, 106:108573. [50] LEEMANS A, BOEREN M, VAN DER GUCHT W, et al. Removal of the N-glycosylation sequon at position N116 located in p27 of the respiratory syncytial virus fusion protein elicits enhanced antibody responses after DNA immunization[J]. Viruses, 2018, 10(8):426. [51] MAS V, NAIR H, CAMPBELL H, et al. Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset[J]. Vaccine, 2018, 36(45):6660-6673. [52] CRUNKHORN S. Viral diseases:zeroing in on RSV vaccine design[J]. Nat Rev Drug Discov, 2014, 13(1):17. [53] LEVELY M E, BANNOW C A, SMITH C W, et al. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes[J]. J Virol, 1991, 65(7):3789-3796. [54] VAN BLEEK G M, POELEN M C, VAN DER MOST R, et al. Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells[J]. J Virol, 2003, 77(2):980-988. [55] KAPLAN B S, HOFSTETTER A R, MCGILL J L, et al. Identification of a DRB3*011:01-restricted CD4+ T cell response against bovine respiratory syncytial virus fusion protein[J]. Front Immunol, 2023, 14:1040075. [56] TAYLOR G, RIJSEWIJK F A M, THOMAS L T, et al. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV[J]. J Gen Virol, 1998, 79(Pt 7):1759-1767. [57] MARTÍNEZ I, MELERO J A. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein[J]. J Gen Virol, 1998, 79(Pt 9):2215-2220. [58] JONES B G, SEALY R E, SURMAN S L, et al. Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model[J]. Vaccine, 2014, 32(26):3264-3273. [59] ZHAN X Y, SLOBOD K S, JONES B G, et al. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats[J]. Int Immunol, 2015, 27(5):229-236. [60] GRIEVES J L, YIN Z W, GARCIA-SASTRE A, et al. A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats[J]. Vaccine, 2018, 36(26):3842-3852. [61] OLMEDILLAS E, CANO O, MARTÍNEZ I, et al. Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses[J]. EMBO Mol Med, 2018, 10(2):175-187. [62] LI H, REN H, ZHANG Y, et al. Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection[J]. Sci Rep, 2021, 11(1):18641. [63] REN H, LI H, CAO L, et al. Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice[J]. Vaccine, 2022, 40(47):6830-6838. [64] LI H, REN H, CAO L, et al. Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice[J]. Biochem Biophys Res Commun, 2022, 618:54-60. [65] LI H, REN H, ZHOU Y Z, et al. HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice[J]. PLoS One, 2022, 17(1):e0262231. [66] MCGILL J L, KELLY S M, KUMAR P, et al. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf[J]. Sci Rep, 2018, 8(1):3021. [67] MADHI S A, POLACK F P, PIEDRA P A, et al. Respiratory syncytial virus vaccination during pregnancy and effects in infants[J]. N Engl J Med, 2020, 383(5):426-439. [68] YAZICI Z, OZAN E, TAMER C, et al. Circulation of indigenous bovine respiratory syncytial virus strains in turkish cattle:the first isolation and molecular characterization[J]. Animals, 2020, 10(9):1700. [69] KUMAGAI A, KAWAUCHI K, ANDOH K, et al. Sequence and unique phylogeny of G genes of bovine respiratory syncytial viruses circulating in Japan[J]. J Vet Diagn Invest, 2021, 33(1):162-166. [70] HOPPE I B A L, DE MEDEIROS A S R, ARNS C W, et al. Bovine respiratory syncytial virus seroprevalence and risk factors in non-vaccinated dairy cattle herds in Brazil[J]. BMC Vet Res, 2018, 14(1):208. [71] KLEM T B, RIMSTAD E, STOKSTAD M. Occurrence and phylogenetic analysis of bovine respiratory syncytial virus in outbreaks of respiratory disease in Norway[J]. BMC Vet Res, 2014, 10:15. |